---
figid: PMC9549728__EMMM-14-e15705-g010
pmcid: PMC9549728
image_filename: EMMM-14-e15705-g010.jpg
figure_link: /pmc/articles/PMC9549728/figure/emmm202215705-fig-0004/
number: Figure 4
figure_title: Varying therapy responses depending on altered signaling pathways
caption: AScheme of the drug library screen of organoid models.BDrug response curves
  upon treatment of organoid models with nutlin‐3a, 5‐FU, oxaliplatin, ibrutinib,
  panobinostat, and entinostat (biological replicates n = 3, data are shown as mean ± SD).CHeat
  map summarizing results of drug library screen categorized by pathway. Color scale
  indicates log10IC50 change in the organoid models compared with normal gastric organoids.
  Two‐tailed Student's t‐test organoid model versus normal organoids (*< 0.05).
article_title: Sensitivity towards HDAC inhibition is associated with RTK/MAPK pathway
  activation in gastric cancer.
citation: Therese Seidlitz, et al. EMBO Mol Med. 2022 Oct;14(10):e15705.
year: '2022'

doi: 10.15252/emmm.202215705
journal_title: EMBO Molecular Medicine
journal_nlm_ta: EMBO Mol Med
publisher_name: John Wiley and Sons Inc.

keywords:
- gastric cancer
- HDACi
- MAPK
- organoids
- Cancer
- Signal Transduction

---
